Proven P-15 bone graft technology now features enhanced handling with addition of purified silk fibers
Find out moreResults from the first prospective clinical study of i-FACTOR bone graft in anterior lumbar interbody fusion surgery published in the Journal of Neurosurgery: Spine
Find out moreApplication is supported by data from a pivotal clinical trial demonstrating that i-FACTOR bone graft can be used as an alternative to autograft harvesting in certain procedures
Find out moreCerapedics today announced closing of a $9 million venture debt financing from GE Capital, Healthcare Financial Services.
Find out moreResults provide significant support to advance i-FACTOR™ Peptide Enhanced Bone Graft for FDA regulatory review.
Find out moreCerapedics today that preliminary outcomes data from the company's FDA Investigational Device Exemption (IDE) clinical trial for i-FACTOR Peptide Enhanced Bone Graft will be presented at the Canaccord Genuity Muscul…
Find out more